Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
David Cole, PhD
PROF, ACCESSION THERAPEUTICS LTD
Accession Therapeutics
Oxford, United Kingdom
Thomas Collet, PhD
PRESIDENT & CEO, CO-FOUNDER, BILAYER THERAPEUTICS, INC.
Bilayer Therapeutics, Inc.
Cambridge, Massachusetts, United States
Viswa Colluru, ACA
FOUNDER & CEO, ENVEDA BIOSCIENCES
Enveda Biosciences
Boulder, Colorado, United States
Grace Colón, PhD
CHAIR; BOARD MEMBER, BLOOM SCIENCE; BIO, MIT, VOYAGER THERAPEUTICS
Biotech Hangout
Richard Colvin, MD, PhD
CHIEF MEDICAL OFFICER, BLUEBIRD BIO
Realizing the Promise of Gene Therapy and Gene Editing: Current Challenges, Opportunities and Trends
Ben Comer
CHIEF EDITOR, LIFE SCIENCE LEADER MAGAZINE
Early to Mid-Stage Biotechs: Creating Partnerships to Enhance Program Value and Accelerate Therapies
Jonah Comstock
EDITOR IN CHIEF, PHARMAPHORUM
Creative funding options for biotechs
John Concato
ASSOCIATE DIRECTOR, OFFICE OF MEDICAL POLICY, CDER, FDA
Real-World Evidence in Regulatory Decision-Making: Enabling its Use Through International CReal-World Evidence in Regulatory Decision-Making: Enabling its Use Through International Collaboration
Placeholder Photo
Ivan Cornella, PhD
CHIEF SCIENTIFIC OFFICER, COVANT THERAPEUTICS
Covant Therapeutics
Boston, Massachusetts, United States
James Cornwall, PhD
SVP BUSINESS DEVELOPMENT, LAUNCH THERAPEUTICS (AN ABINGWORTH/CARLYLE COMPANY)
Beyond Equity: Extreme Innovation in Financing for Public Biotechs